Extra Glycemic Impacts of GLP-1 Receptor Agonists: Benefits of a Class Effect?

Open Journal of Endocrine and Metabolic Diseases

doi 10.4236/ojemd.2016.61007

Full Text

Abstract

Available in

Date

Authors

Publisher

Scientific Research Publishing, Inc,

Related search

The Cardiovascular Effects of GLP-1 Receptor Agonists

Cardiovascular Therapeutics
MedicineCardiovascular MedicinePharmacologyCardiology
2010English

Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2014English

Β-Arrestin-Biased Agonists of the GLP-1 Receptor From Β-Amino Acid Residue Incorporation Into GLP-1 Analogues

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2016English

Role and Development of GLP-1 Receptor Agonists in the Management of Diabetes

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2009English

Clinical Trial Highlights – GLP-1 Agonists

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2020English

Is There a Justification for Classifying GLP-1 Receptor Agonists as Basal and Prandial?

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Combination Therapy With GLP-1 Receptor Agonists and Basal Insulin: A Systematic Review of the Literature

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

Selecting GLP-1 Agonists in the Management of Type 2 Diabetes: Differential Pharmacology and Therapeutic Benefits of Liraglutide and Exenatide

Therapeutics and Clinical Risk Management
2010English

Cardiovascular Benefits of Native GLP-1 and Its Metabolites: An Indicator for GLP-1-Therapy Strategies

Frontiers in Physiology
Physiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy